Atherectomy Devices Market Size By Product (Directional Atherectomy Devices, Laser Atherectomy Devices), By Application (Peripheral Vascular Applications, Coronary Applications), By End-use (Hospitals, ASCs) & Forecast, 2023 – 2032

Atherectomy Devices Market Size By Product (Directional Atherectomy Devices, Laser Atherectomy Devices), By Application (Peripheral Vascular Applications, Coronary Applications), By End-use (Hospitals, ASCs) & Forecast, 2023 – 2032

Atherectomy Devices Market Size

Atherectomy Devices Market size was worth USD 660 million in 2022 and is anticipated to grow significantly at over 7% CAGR from 2023 to 2032 attributed to the rising preference for minimally invasive surgical procedures.
 

The acceptance of minimally invasive operations has significantly soared among patients as they offer several advantages, such as minimal postoperative discomfort, shorter hospital stay, and reduced blood loss. The ongoing technological improvements have led to the evolution of less invasive percutaneous revascularization treatments in atherectomy. The growing usage of improved tools in atherectomy treatments for less scarring and smaller incisions on the body will also drive the industry growth.

The rising shortage of competent healthcare workers is likely to restrain the atherectomy devices market development to some extent. According to the American Association of Medical Colleges, the U.S. may face a shortfall of around 23,000 surgeons by 2032. Despite the financial ease, healthcare institutions are not able to employ atherectomy equipment due to scarcity, and the lack of personnel with necessary skills to run the systems. Additionally, the surge in the number of patients undergoing traditional open surgical treatments will limit the business statistics.
 

COVID-19 Impact

The COVID-19 outbreak had detrimental impact on the atherectomy device industry. To prevent the spread of the virus, governments across the world instituted countrywide lockdowns resulting in the considerable decrease in various cardiac procedures internationally. According to NCBI research, the number of operations conducted in the U.S. in April 2020 was 43% lower than pre-pandemic levels. The rescheduling and postponement of elective and non-invasive operations lowered the product demand in these procedures. However, the currently declining COVID-19 infection rates and patients, as well as the increased procedure volume are expected to boost the market expansion.
 

Atherectomy Devices Market Trends

In recent years, the treatment for lower extremity peripheral vascular diseases has evolved due to the rising advancements in percutaneous revascularization. Several modern devices are witnessing increased patient interest for treating infrapopliteal and femoropopliteal diseases. These advanced devices integrate technologies, including plaque excisional atherectomy, laser catheters, drug-eluting stents, mechanical thrombectomy, and cryoplasty. The increasing R&D efforts led by prominent industry players for developing innovative and highly advanced products will also create novel atherectomy devices market growth opportunities.
 

Atherectomy Devices Market Analysis

Orbital atherectomy devices industry generated USD 204 million in 2022 and is expected to witness robust growth through 2032. Orbital atherectomy devices are gaining significant traction owing to their several clinical benefits in minimally invasive procedures. These devices are designed to preserve the natural vessel anatomy while not damaging the healthy vessel walls. Their growing usage to assist in maintaining the integrity of the treated artery and reducing the risk of complications, such as vessel perforation or dissection will drive the market progression.
 

The atherectomy devices market from the ambulatory surgical centers segment is estimated to amass more than USD 404 million by 2032. Ambulatory surgical centers (ASCs) are increasingly preferred due to the high availability of comprehensive range of treatments and the growing adoption of advanced technology and equipment to cater to the patient population undergoing several diagnoses and treatments. Moreover, the improving reimbursement scenarios related to several surgeries in these facilities will propel the segment growth.
 

North America held the largest revenue share in the atherectomy devices industry and is expected to cross a valuation of USD 865 million by 2032. The growth can be ascribed to the presence of significant industry participants and the rising awareness of the advantages of precision atherectomy devices for both diagnosis and treatment. According to the CDC estimates, around 6.5 million people aged 40 and above were suffering from PAD in 2022. Moreover, the growing disease-prone population as well as the expanding elderly patient pool will drive regional market expansion.
 

Atherectomy Devices Market Share

• Medtronic plc
•  Avinger
•  Boston Scientific
• Cardiovascular Systems Inc
•  Koninklijke Philips N.V
•  Abbott Laboratories
•  AngioDynamics Inc
• Becton
• Dickinson and Company
•  Terumo Corporation
•  Cardinal Health Inc.
•  Nipro Corporation
• Biomerics LLC
• Rex Medical

are some leading players operating in the global atherectomy devices market landscape.
 

Atherectomy Devices Industry News

• In August 2022, AngioDynamics, Inc., announced that its Auryon Atherectomy System obtained the 510(k) clearance for an extended indication to include arterial thrombectomy.
   
• In February 2023, Abbott signed a formal agreement to purchase Cardiovascular Systems Inc., a medical device business that develops novel atherectomy systems utilized in the treatment of peripheral and coronary artery diseases.
   

This market research report on atherectomy devices includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments

Click here to Buy Section of this Report

Market, By Product

• Directional Atherectomy Devices
• Orbital Atherectomy Devices
• Laser Atherectomy Devices
• Rotational Atherectomy Devices

Market, By Application

• Peripheral Vascular Applications
• Coronary Applications

Market, By End-Use

• Hospitals
• Ambulatory Surgical Centers

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Vietnam
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Peru
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey
  • Israel
  • Iran